Bristol-Myers Squibb is splitting off its holdings in infant formula maker Mead Johnson Nutrition in order to focus on its biopharmaceutical business. The New York-based drug maker, which owns about 80 percent of Mead stock, expects the deal to add to…

Email this Article
Add to del.icio.us
Add to digg
Add to Facebook




Bristol-Myers Squibb – Business – New York City – Pharmaceutical industry – Bristol

Read the rest here:
Bristol-Myers splits off Mead Johnson Nutrition